STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer

Reuters12-17

STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer

STAAR Surgical Company has provided an update regarding its agreement with Alcon, under which Alcon will acquire STAAR for $30.75 per share in cash, representing a 74% premium to the 90-day volume-weighted average price. In communications following the agreement, STAAR clarified that although several parties expressed vague interest prior to the announcement, none submitted a proposal or pursued due diligence during the go-shop period. Additionally, a party believed to be FountainVest initiated contact late in the process but ultimately declined to execute a nondisclosure agreement even after STAAR accepted its requested changes. No alternative proposals were received before the go-shop period expired. The company reiterated that Alcon’s offer represents certain and immediate cash value for STAAR’s shareholders. A virtual Special Meeting of Stockholders has been scheduled for December 19, 2025, to consider the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251217865184) on December 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592633911?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 23:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592633911","market":"nz","top_or_hot":-1,"title":"STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> has provided an update regarding its agreement with Alcon, under which Alcon will acquire STAAR for $30.75 per share in cash, representing a 74% premium to the 90-day volume-weighted average price. In communications following the agreement, STAAR clarified that although several parties expressed vague interest prior to the announcement, none submitted a proposal or pursued due diligence during the go-shop period. Additionally, a party believed to be FountainVest initiated contact late in the process but ultimately declined to execute a nondisclosure agreement even after STAAR accepted its requested changes. No alternative proposals were received before the go-shop period expired. The company reiterated that Alcon’s offer represents certain and immediate cash value for STAAR’s shareholders. A virtual Special Meeting of Stockholders has been scheduled for December 19, 2025, to consider the transaction.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251217865184) on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSTAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-17 23:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> has provided an update regarding its agreement with Alcon, under which Alcon will acquire STAAR for $30.75 per share in cash, representing a 74% premium to the 90-day volume-weighted average price. In communications following the agreement, STAAR clarified that although several parties expressed vague interest prior to the announcement, none submitted a proposal or pursued due diligence during the go-shop period. Additionally, a party believed to be FountainVest initiated contact late in the process but ultimately declined to execute a nondisclosure agreement even after STAAR accepted its requested changes. No alternative proposals were received before the go-shop period expired. The company reiterated that Alcon’s offer represents certain and immediate cash value for STAAR’s shareholders. A virtual Special Meeting of Stockholders has been scheduled for December 19, 2025, to consider the transaction.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251217865184) on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL6PrbcM:1","article_id":"2592633911","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592633911","pubTimestamp":1765986920,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"STAAR Surgical Company has provided an update regarding its agreement with Alcon, under which Alcon will acquire STAAR for $30.75 per share in cash, representing a 74% premium to the 90-day volume-weighted average price. In communications following the agreement, STAAR clarified that although several parties expressed vague interest prior to the announcement, none submitted a proposal or pursued due diligence during the go-shop period. Additionally, a party believed to be FountainVest initiated contact late in the process but ultimately declined to execute a nondisclosure agreement even after STAAR accepted its requested changes. No alternative proposals were received before the go-shop period expired. The company reiterated that Alcon’s offer represents certain and immediate cash value for STAAR’s shareholders. A virtual Special Meeting of Stockholders has been scheduled for December 19, 2025, to consider the transaction.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","STAA":"STAAR Surgical Company"},"translate_title":"STAAR Surgical股东将对爱尔康每股30.75美元的现金要约进行投票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":0.9},"content_text":"STAAR Surgical Stockholders to Vote on Alcon's $30.75 Per Share Cash Offer\n    \n\nSTAAR Surgical Company has provided an update regarding its agreement with Alcon, under which Alcon will acquire STAAR for $30.75 per share in cash, representing a 74% premium to the 90-day volume-weighted average price. In communications following the agreement, STAAR clarified that although several parties expressed vague interest prior to the announcement, none submitted a proposal or pursued due diligence during the go-shop period. Additionally, a party believed to be FountainVest initiated contact late in the process but ultimately declined to execute a nondisclosure agreement even after STAAR accepted its requested changes. No alternative proposals were received before the go-shop period expired. The company reiterated that Alcon’s offer represents certain and immediate cash value for STAAR’s shareholders. A virtual Special Meeting of Stockholders has been scheduled for December 19, 2025, to consider the transaction.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251217865184) on December 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592633911","isCrawlerRequest":true}